There are blood tests for RSV antibodies – the immune system's response to the virus. These tests are not routinely used to diagnose RSV infections but may be used by public health officials to track RSV infections.
There is no specific treatment for RSV. Care for a person with RSV is primarily supportive, to minimize pain and fever and ease breathing.
There is a short-term drug therapy that is given to some high-risk people. It does not prevent or cure RSV infection, but it lowers the risk of RSV infecting the lower respiratory tract, reducing the need for hospitalization. This immunotherapy, called palivizumab, may be given to newborns in the intensive care nursery to protect them during RSV season. Premature infants can be especially vulnerable to RSV.
This article was last reviewed on November 21, 2016. | This article was last modified on November 21, 2016.
The review date indicates when the article was last reviewed from beginning to end to ensure that it reflects the most current science. A review may not require any modifications to the article, so the two dates may not always agree.
The modified date indicates that one or more changes were made to the article. Such changes may or may not result from a full review of the article, so the two dates may not always agree.